Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates
Provided By GlobeNewswire
Last update: Mar 31, 2025
Recorded noted regulatory successes with FDA general use clearance and granting of CE Mark in the EU
Advanced commercialization globally, signing new customer and channel partner agreements for Nanox.ARC and Nanox AI
Read more at globenewswire.com
